Regulatory mechanisms and their therapeutic implications of interleukin-12 production in immune cells.
Kang BY, Kim E, Kim TS
Cell Signal, 2005.06
52
Inhibitory activity of a ceramide library on interleukin-4 production from activated T cells.
Park J, Li Q, Chang Y-T, Kim TS
Bioorg. Med. Chem., 2005.04
53
Induction of human promyelocytic leukemia cell differentiation via a PKC/ERK pathway by helenalin, a pseudoguainolide sesquiterpene lactone.
Kim, SH, Oh SM, Kim TS
Eur. J. Pharmacol., 2005.03
54
IL-18 enhances SCF production of melanoma cells by regulating ROI and p38 MAPK activity.
Hue J, Kim A, Song H, Choi I, Park H, Kim TS, Lee WJ, Kang H, Cho D
Immunol. Lett., 2005.01
55
Resistance to cytotoxic chemotherapy is induced by NK cells in non-hodgkin’s lymphoma cells.
Cho D, Kim YI, Kang JS, Hahm E, Yang Y, Kim D, Kim S, Kim YS, Hur D, Park H, Hwang YI, Kim TS, Lee WJ
J Clin Immunol, 2004.09
56
Increased expression of IL-18 in cutaneous Graft-versus-Host Disease.
Park HJ, Kim JE, Lee JY, Cho BK, Lee WJ, Kim TS, Yun D, Cho DH
Immunol. Lett., 2004.08
57
Enhancement of interleukin-4 production in activated CD4+ T cells by diphthalate plasticizers via NF-AT activation.
Lee MH, Park J, Chung SW, Kang BY, Kim SH, Kim TS
Int. Arch Allergy Immunol., 2004.07
58
Generation of tumor-specific cytotoxic T lymphocyte and prolongation of the survival of tumor-bearing mice interlukin-18-secreting fibroblasts loaded with an epitope peptide.
Chung SW, Cohen EP, Kim TS
Vaccine, 2004.06
59
Exposure to 4-tert-octylphenol, an environmentally persistent alkylphenol, enhances interleukin-4 production in T cells via NF-AT activation.
Lee MH, Kim E, Kim TS
Toxicol. Appl. Pharmacol., 2004.05
60
Application of Sulforhodamine B Assay for Determining Cytotoxicity of Vibrio vulnificus against Human Intestinal Cells.